Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content

<jats:sec><jats:title>Objective</jats:title><jats:p><jats:italic>Plasmodium falciparum</jats:italic> is epileptogenic and in malaria endemic areas, is a leading cause of acute seizures. In these areas, asymptomatic infections are common but considered benign and so, are not treated. The effects of such infections on seizures in patients with epilepsy is unknown. This study examined the relationship between <jats:italic>P. falciparum</jats:italic> infection and seizure control in children with a unique epilepsy type, the nodding syndrome.</jats:p></jats:sec><jats:sec><jats:title>Design</jats:title><jats:p>This cross-sectional study was nested in an ongoing trial ‘Doxycycline for the treatment of nodding syndrome (<jats:ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="clintrialgov" xlink:href="NCT02850913">NCT02850913</jats:ext-link>)’. We hypothesised that, in patients with epilepsy, infection by <jats:italic>P. falciparum,</jats:italic> including asymptomatic infections, increases the risk of seizures and impairs seizure control.</jats:p></jats:sec><jats:sec><jats:title>Setting and participants</jats:title><jats:p>Participants were Ugandan children with nodding syndrome, age ≥8 years, receiving sodium valproate. All had standardised testing including documentation of the number of seizures in the past month, a rapid malaria test and if positive, the peripheral blood parasite density.</jats:p></jats:sec><jats:sec><jats:title>Outcomes</jats:title><jats:p>The primary outcome was the number of seizures in the past month (30 days).</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>A total of 164/240 (68%) had malaria. Asymptomatic infections (without fever) were seen in 160/240 (67%) and symptomatic infections in 4/240 (2.7%). In participants without malaria, the median (IQR) number of seizures in the past month was 2.0 (1.0–4.0) and it was 4.0 (2.0–7.5) in participants with malaria, p=0.017. The number of seizures in asymptomatic persons was 3.0 (IQR 2.0–7.3) and 6.0 (IQR 4.0–10.0) in symptomatic individuals, p=0.024. Additionally, in asymptomatic patients, a positive correlation was observed between the parasite density and number of seizures, r=0.33, p<jats:italic>=</jats:italic>0.002.</jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p>In patients with nodding syndrome, both asymptomatic and symptomatic malaria are associated with an increased risk of seizures and poorer seizure control. Similar effects should be examined in other epilepsy disorders. Malaria prevention should be strengthened for these patients and chemotreatment and prevention studies considered to improve seizure control.</jats:p></jats:sec>

Original publication

DOI

10.1136/bmjopen-2018-023624

Type

Journal article

Journal

BMJ Open

Publisher

BMJ

Publication Date

10/2018

Volume

8

Pages

e023624 - e023624